STOCKHOLM, January 12, 2026--(BUSINESS WIRE)--At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, ...
Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...
Powered by Google's Genie 3 model, the world-building AI tool is designed to help train AI agents in 3D scenarios, but it ...